Bader Almuzzaini

802 total citations
27 papers, 511 citations indexed

About

Bader Almuzzaini is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Bader Almuzzaini has authored 27 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Genetics and 5 papers in Oncology. Recurrent topics in Bader Almuzzaini's work include Genomics and Chromatin Dynamics (6 papers), RNA Research and Splicing (6 papers) and Genetic Syndromes and Imprinting (3 papers). Bader Almuzzaini is often cited by papers focused on Genomics and Chromatin Dynamics (6 papers), RNA Research and Splicing (6 papers) and Genetic Syndromes and Imprinting (3 papers). Bader Almuzzaini collaborates with scholars based in Saudi Arabia, Sweden and United States. Bader Almuzzaini's co-authors include Piergiorgio Percipalle, Aishe A. Sarshad, Ann-Kristin Östlund Farrants, Ann‐Kristin Östlund Farrants, Abdelbaset Mohamed Elasbali, Bassam Ahmed Almutlaq, Wedad Saeed Al-Qahtani, Hussain Gadelkarim Ahmed, Gadah Albasher and Huda H. Al‐Khalaf and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Bader Almuzzaini

26 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bader Almuzzaini Saudi Arabia 12 303 94 79 79 38 27 511
Yujing Dang United States 13 282 0.9× 142 1.5× 40 0.5× 63 0.8× 33 0.9× 16 441
Michael W. Rowe Denmark 7 178 0.6× 47 0.5× 75 0.9× 38 0.5× 37 1.0× 12 359
Swastika Sur United States 10 186 0.6× 40 0.4× 52 0.7× 41 0.5× 44 1.2× 17 362
Songlin Piao China 10 219 0.7× 60 0.6× 85 1.1× 22 0.3× 67 1.8× 15 398
Pei Kee Goh Australia 6 285 0.9× 43 0.5× 147 1.9× 63 0.8× 77 2.0× 8 564
Haiyan Zhu China 9 243 0.8× 83 0.9× 47 0.6× 13 0.2× 66 1.7× 26 392
Yasuhito Kato Japan 13 275 0.9× 94 1.0× 116 1.5× 28 0.4× 115 3.0× 29 611
Raquel Pluvinet Spain 11 243 0.8× 53 0.6× 56 0.7× 27 0.3× 99 2.6× 19 434
Noah Post United States 10 440 1.5× 34 0.4× 24 0.3× 41 0.5× 61 1.6× 11 547

Countries citing papers authored by Bader Almuzzaini

Since Specialization
Citations

This map shows the geographic impact of Bader Almuzzaini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bader Almuzzaini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bader Almuzzaini more than expected).

Fields of papers citing papers by Bader Almuzzaini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bader Almuzzaini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bader Almuzzaini. The network helps show where Bader Almuzzaini may publish in the future.

Co-authorship network of co-authors of Bader Almuzzaini

This figure shows the co-authorship network connecting the top 25 collaborators of Bader Almuzzaini. A scholar is included among the top collaborators of Bader Almuzzaini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bader Almuzzaini. Bader Almuzzaini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Matou‐Nasri, Sabine, et al.. (2022). Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling. PLoS ONE. 17(5). e0267855–e0267855. 7 indexed citations
5.
Alaamery, Manal, Jahad Alghamdi, Salam Massadeh, et al.. (2022). Analysis of chronic kidney disease patients by targeted next-generation sequencing identifies novel variants in kidney-related genes. Frontiers in Genetics. 13. 886038–886038. 2 indexed citations
7.
Rashid, Mamoon, Rizwan Ali, Bader Almuzzaini, et al.. (2021). Discovery of a novel potentially transforming somatic mutation in CSF2RB gene in breast cancer. Cancer Medicine. 10(22). 8138–8150. 7 indexed citations
8.
Umair, Muhammad, Muhammad Bilal, Bader Almuzzaini, et al.. (2021). Biallelic variant in DACH1, encoding Dachshund Homolog 1, defines a novel candidate locus for recessive postaxial polydactyly type A. Genomics. 113(4). 2495–2502. 18 indexed citations
9.
Alfadhel, Majid, Muhammad Umair, Bader Almuzzaini, et al.. (2021). Identification of the TTC26 Splice Variant in a Novel Complex Ciliopathy Syndrome with Biliary, Renal, Neurological, and Skeletal Manifestations. Molecular Syndromology. 12(3). 133–140. 8 indexed citations
10.
Alghamdi, Jahad, Bader Almuzzaini, Azra Mahmud, et al.. (2020). Blood pressure–lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials. European Journal of Clinical Pharmacology. 76(12). 1745–1754. 6 indexed citations
11.
Alsultan, Abdullah, et al.. (2020). Population pharmacokinetics of busulfan in Saudi pediatric patients undergoing hematopoietic stem cell transplantation. International Journal of Clinical Pharmacy. 42(2). 703–712. 5 indexed citations
12.
Balwi, Mohammed Al, et al.. (2020). The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort. Scientific Reports. 10(1). 11613–11613. 13 indexed citations
14.
Hussain, Shabir, Muhammad Bilal, Bader Almuzzaini, et al.. (2020). Biallelic variants in four genes underlying recessive osteogenesis imperfecta. European Journal of Medical Genetics. 63(8). 103954–103954. 30 indexed citations
15.
Al‐Qattan, Mohammad M., et al.. (2019). A classification system for split-hand/ foot malformation (SHFM): A proposal based on 3 pedigrees with WNT10B mutations. European Journal of Medical Genetics. 63(3). 103738–103738. 5 indexed citations
16.
Almuzzaini, Bader, Marisa A. P. Baptista, Mariana M.S. Oliveira, et al.. (2017). Nuclear Wiskott–Aldrich syndrome protein co-regulates T cell factor 1-mediated transcription in T cells. Genome Medicine. 9(1). 91–91. 15 indexed citations
17.
Almuzzaini, Bader, Aishe A. Sarshad, Aldwin Suryo Rahmanto, et al.. (2016). In β‐actin knockouts, epigenetic reprogramming and rDNA transcription inactivation lead to growth and proliferation defects. The FASEB Journal. 30(8). 2860–2873. 32 indexed citations
18.
Almuzzaini, Bader, Aishe A. Sarshad, Ann-Kristin Östlund Farrants, & Piergiorgio Percipalle. (2015). Nuclear myosin 1 contributes to a chromatin landscape compatible with RNA polymerase II transcription activation. BMC Biology. 13(1). 35–35. 45 indexed citations
19.
Sarshad, Aishe A., Martin Corcoran, Bader Almuzzaini, et al.. (2014). Glycogen Synthase Kinase (GSK) 3β Phosphorylates and Protects Nuclear Myosin 1c from Proteasome-Mediated Degradation to Activate rDNA Transcription in Early G1 Cells. PLoS Genetics. 10(6). e1004390–e1004390. 24 indexed citations
20.
Sarshad, Aishe A., Fatemeh Sadeghifar, Émilie Louvet, et al.. (2013). Nuclear Myosin 1c Facilitates the Chromatin Modifications Required to Activate rRNA Gene Transcription and Cell Cycle Progression. PLoS Genetics. 9(3). e1003397–e1003397. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026